81_FR_65103 81 FR 64920 - Center For Scientific Review; Notice of Closed Meetings

81 FR 64920 - Center For Scientific Review; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 183 (September 21, 2016)

Page Range64920-64921
FR Document2016-22666

Federal Register, Volume 81 Issue 183 (Wednesday, September 21, 2016)
[Federal Register Volume 81, Number 183 (Wednesday, September 21, 2016)]
[Notices]
[Pages 64920-64921]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-22666]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center For Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.


[[Page 64921]]


    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Prokaryotic Gene Expression.
    Date: October 5, 2016.
    Time: 9:00 a.m. to 11:00 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Richard A. Currie, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 1108, MSC 7890, Bethesda, MD 
20892, (301) 435-1219, [email protected].

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: Musculoskeletal, Oral and Skin Sciences 
Integrated Review Group; Musculoskeletal Rehabilitation Sciences 
Study Section.
    Date: October 17, 2016.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Westin BWI, 1110 Old Elkridge Landing Road, Linthicum, MD 
21090.
    Contact Person: Maria Nurminskaya, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, Bethesda, MD 20892, (301) 435-1222, 
[email protected].

    Name of Committee: Infectious Diseases and Microbiology 
Integrated Review Group; Virology--B Study Section.
    Date: October 17-18, 2016.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Residence Inn Alexandria Old Town, 1456 Duke St, 
Alexandria, VA 22314.
    Contact Person: John C. Pugh, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 1206, MSC 7808, Bethesda, MD 20892, (301) 435-
2398, [email protected].

    Name of Committee: Integrative, Functional and Cognitive 
Neuroscience Integrated Review Group; Mechanisms of Sensory, 
Perceptual, and Cognitive Processes Study Section.
    Date: October 17-18, 2016.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Washington Plaza Hotel, 10 Thomas Circle NW., Washington, 
DC 20005.
    Contact Person: Kirk Thompson, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 5184, MSC 7844, Bethesda, MD 20892, 301-435-
1242, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Vaccine Related Immune Activation and Immunoregulation.
    Date: October 18, 2016.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Doubletree Hotel Bethesda, (Formerly Holiday Inn Select), 
8120 Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Liying Guo, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 4016F, Bethesda, MD 20892, 301-435-0908, 
[email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR-16-114: Spermatogenic Stem Cell Culture Systems to 
Preserve and Restore Reproductive Capacity in Males.
    Date: October 19, 2016.
    Time: 2:00 p.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Clara M. Cheng, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 6170, MSC 7892, Bethesda, MD 
20892, 301-435-1041, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: September 15, 2016.
Carolyn Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-22666 Filed 9-20-16; 8:45 am]
 BILLING CODE 4140-01-P



                                                  64920                          Federal Register / Vol. 81, No. 183 / Wednesday, September 21, 2016 / Notices

                                                  III. Listing of New Entries                                          added as modifications to the list of
                                                    In table 2, FDA provides the listing of                            recognized standards under Recognition
                                                  new entries and consensus standards                                  List Number: 045.

                                                                                                 TABLE 2—NEW ENTRIES TO THE LIST OF RECOGNIZED STANDARDS
                                                                Recognition No.                                                           Title of standard 1                                              Reference No. and date

                                                                                                             A. General I (Quality Systems/Risk Management) (QS/RM)

                                                  5–110 ..............................................   Packaged-Products for Parcel Delivery System Shipment 70 kg (150                             ISTA 3A 2008.
                                                                                                           lb) or Less.
                                                  5–111 ..............................................   Packaged-Products for Less-Than-Truckload (LTL) Shipment .............                       ISTA 3B 2012.
                                                  5–112 ..............................................   Unitized Loads of Same Product ...........................................................   ISTA 3E 2009.

                                                                                                                                 B. In Vitro Diagnostics (IVD)

                                                  7–265 ..............................................   Liquid Chromatography-Mass Spectrometry Methods; Approved                                    C62–A: 2014.
                                                                                                           Guideline.
                                                  7–266 ..............................................   A Framework for Using CLSI Documents to Evaluate Clinical Labora-                            EP19 Second Edition: 2015.
                                                                                                           tory Measurement Procedures.

                                                                                                                                           C. Ophthalmic

                                                  10–101 ............................................    Ophthalmic optics—Contact lenses and contact lens care products—                             ISO 18189 First edition 2016–06–
                                                                                                          Cytotoxicity testing of contact lenses in combination with lens care                          01.
                                                                                                          solution to evaluate lens/solution interactions.
                                                  10–102 ............................................    American National Standard for Ophthalmics—Light Hazard Protec-                              ANSI Z80.36—2016.
                                                                                                          tion for Ophthalmic Instruments.
                                                     1 All   standard titles in this table conform to the style requirements of the respective organizations.


                                                  IV. List of Recognized Standards                                     information: (1) Title of the standard, (2)                    the searchable database for ‘‘FDA
                                                                                                                       any reference number and date, (3)                             Recognized Consensus Standards’’ at
                                                     FDA maintains the Agency’s current
                                                                                                                       name and address of the national or                            http://www.fda.gov/MedicalDevices/
                                                  list of FDA Recognized Consensus
                                                  Standards in a searchable database that                              international standards development                            DeviceRegulationandGuidance/
                                                  may be accessed directly at FDA’s                                    organization, (4) a proposed list of                           Standards.
                                                  Internet site at http://                                             devices for which a declaration of
                                                                                                                                                                                        Dated: September 15, 2016.
                                                  www.accessdata.fda.gov/scripts/cdrh/                                 conformity to this standard should
                                                                                                                       routinely apply, and (5) a brief                               Leslie Kux,
                                                  cfdocs/cfStandards/search.cfm. FDA                                                                                                  Associate Commissioner for Policy.
                                                  will incorporate the modifications and                               identification of the testing or
                                                  revisions described in this notice into                              performance or other characteristics of                        [FR Doc. 2016–22710 Filed 9–20–16; 8:45 am]

                                                  the database and, upon publication in                                the device(s) that would be addressed                          BILLING CODE 4164–01–P

                                                  the Federal Register, this recognition of                            by a declaration of conformity.
                                                  consensus standards will be effective.                               VI. Electronic Access
                                                  FDA will announce additional                                                                                                        DEPARTMENT OF HEALTH AND
                                                  modifications and revisions to the list of  You may obtain a copy of ‘‘Guidance                                                     HUMAN SERVICES
                                                  recognized consensus standards, as       on the Recognition and Use of
                                                                                                                                                                                      National Institutes of Health
                                                  needed, in the Federal Register once a   Consensus Standards’’ by using the
                                                  year, or more often if necessary.        Internet. The Center for Devices and                                                       Center For Scientific Review; Notice of
                                                  Beginning with Recognition List 033,     Radiological Health (CDRH) maintains a                                                     Closed Meetings
                                                  FDA no longer announces minor            site on the Internet for easy access to
                                                  revisions to the list of recognized      information including text, graphics,                                                        Pursuant to section 10(d) of the
                                                  consensus standards such as technical    and files that you may download to a                                                       Federal Advisory Committee Act, as
                                                  contact person, devices affected,        personal computer with access to the                                                       amended (5 U.S.C. App.), notice is
                                                  processes affected, Code of Federal      Internet. Updated on a regular basis, the                                                  hereby given of the following meetings.
                                                  Regulations citations, and product       CDRH home page, http://www.fda.gov/
                                                  codes.                                   MedicalDevices, includes a link to                                                           The meetings will be closed to the
                                                                                           standards-related documents including                                                      public in accordance with the
                                                  V. Recommendation of Standards for                                                                                                  provisions set forth in sections
                                                                                           the guidance and the current list of
                                                  Recognition by FDA                                                                                                                  552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
                                                                                           recognized standards. After publication
                                                     Any person may recommend              in the Federal Register, this notice                                                       as amended. The grant applications and
                                                  consensus standards as candidates for    announcing ‘‘Modification to the List of                                                   the discussions could disclose
mstockstill on DSK3G9T082PROD with NOTICES




                                                  recognition under section 514 of the     Recognized Standards, Recognition List                                                     confidential trade secrets or commercial
                                                  FD&C Act by submitting such              Number: 045’’ will be available at http://                                                 property such as patentable material,
                                                  recommendations, with reasons for the    www.fda.gov/MedicalDevices/                                                                and personal information concerning
                                                  recommendation, to standards@            DeviceRegulationandGuidance/                                                               individuals associated with the grant
                                                  cdrh.fda.gov. To be properly considered, Standards/ucm123792.htm. You may                                                           applications, the disclosure of which
                                                  such recommendations should contain,     access ‘‘Guidance on the Recognition                                                       would constitute a clearly unwarranted
                                                  at a minimum, the following              and Use of Consensus Standards,’’ and                                                      invasion of personal privacy.


                                             VerDate Sep<11>2014        18:19 Sep 20, 2016       Jkt 238001     PO 00000     Frm 00052     Fmt 4703    Sfmt 4703    E:\FR\FM\21SEN1.SGM         21SEN1


                                                                          Federal Register / Vol. 81, No. 183 / Wednesday, September 21, 2016 / Notices                                                 64921

                                                    Name of Committee: Center for Scientific                Place: Doubletree Hotel Bethesda,                     Time: 8:00 a.m. to 6:00 p.m.
                                                  Review Special Emphasis Panel; Prokaryotic              (Formerly Holiday Inn Select), 8120                     Agenda: To review and evaluate
                                                  Gene Expression.                                        Wisconsin Avenue, Bethesda, MD 20814.                 programmatic and personnel issues.
                                                    Date: October 5, 2016.                                  Contact Person: Liying Guo, Ph.D.,                    Place: Bethesda Marriott Suites, 6711
                                                    Time: 9:00 a.m. to 11:00 a.m.                         Scientific Review Officer, Center for                 Democracy Boulevard, Bethesda, MD 20817.
                                                    Agenda: To review and evaluate grant                  Scientific Review, National Institutes of               Contact Person: Robert S. Balaban, Ph.D.,
                                                  applications.                                           Health, 6701 Rockledge Drive, Room 4016F,             Scientific Director, National Heart, Lung, and
                                                    Place: National Institutes of Health, 6701            Bethesda, MD 20892, 301–435–0908, lguo@               Blood Institute, National Institutes of Health,
                                                  Rockledge Drive, Bethesda, MD 20892,                    mail.nih.gov.                                         Building 10, 10 Center Drive, CRC, 4th Floor,
                                                  (Telephone Conference Call).                              Name of Committee: Center for Scientific            Room 1581, Bethesda, MD 20892, 301–496–
                                                    Contact Person: Richard A. Currie, Ph.D.,             Review Special Emphasis Panel; PAR–16–                2116, balabanr@nhlbi.nih.gov.
                                                  Scientific Review Officer, Center for                   114: Spermatogenic Stem Cell Culture                    Information is also available on the
                                                  Scientific Review, National Institutes of               Systems to Preserve and Restore                       Institute’s/Center’s home page:
                                                  Health, 6701 Rockledge Drive, Room 1108,                Reproductive Capacity in Males.                       www.nhlbi.nih.gov/meetings/index.htm,
                                                  MSC 7890, Bethesda, MD 20892, (301) 435–                  Date: October 19, 2016.                             where an agenda and any additional
                                                  1219, currieri@csr.nih.gov.                               Time: 2:00 p.m. to 6:00 p.m.                        information for the meeting will be posted
                                                    This notice is being published less than 15             Agenda: To review and evaluate grant                when available.
                                                  days prior to the meeting due to the timing             applications.                                         (Catalogue of Federal Domestic Assistance
                                                  limitations imposed by the review and                     Place: National Institutes of Health, 6701          Program Nos. 93.233, National Center for
                                                  funding cycle.                                          Rockledge Drive, Bethesda, MD 20892,                  Sleep Disorders Research; 93.837, Heart and
                                                    Name of Committee: Musculoskeletal, Oral              (Telephone Conference Call).                          Vascular Diseases Research; 93.838, Lung
                                                                                                            Contact Person: Clara M. Cheng, Ph.D.,              Diseases Research; 93.839, Blood Diseases
                                                  and Skin Sciences Integrated Review Group;
                                                                                                          Scientific Review Officer, Center for                 and Resources Research, National Institutes
                                                  Musculoskeletal Rehabilitation Sciences
                                                                                                          Scientific Review, National Institutes of             of Health, HHS)
                                                  Study Section.
                                                    Date: October 17, 2016.                               Health, 6701 Rockledge Drive, Room 6170,                Dated: September 15, 2016.
                                                    Time: 8:00 a.m. to 5:00 p.m.                          MSC 7892, Bethesda, MD 20892, 301–435–
                                                                                                          1041, chengc@csr.nih.gov.                             Michelle Trout,
                                                    Agenda: To review and evaluate grant                                                                        Program Analyst, Office of Federal Advisory
                                                  applications.                                           (Catalogue of Federal Domestic Assistance
                                                                                                          Program Nos. 93.306, Comparative Medicine;            Committee Policy.
                                                    Place: Westin BWI, 1110 Old Elkridge
                                                  Landing Road, Linthicum, MD 21090.                      93.333, Clinical Research, 93.306, 93.333,            [FR Doc. 2016–22667 Filed 9–20–16; 8:45 am]
                                                    Contact Person: Maria Nurminskaya, Ph.D.,             93.337, 93.393–93.396, 93.837–93.844,                 BILLING CODE 4140–01–P
                                                  Scientific Review Officer, Center for                   93.846–93.878, 93.892, 93.893, National
                                                  Scientific Review, National Institutes of               Institutes of Health, HHS)
                                                  Health, Bethesda, MD 20892, (301) 435–1222,               Dated: September 15, 2016.                          DEPARTMENT OF HEALTH AND
                                                  nurminskayam@csr.nih.gov.                                                                                     HUMAN SERVICES
                                                                                                          Carolyn Baum,
                                                    Name of Committee: Infectious Diseases
                                                                                                          Program Analyst, Office of Federal Advisory           National Institutes of Health
                                                  and Microbiology Integrated Review Group;
                                                                                                          Committee Policy.
                                                  Virology—B Study Section.
                                                    Date: October 17–18, 2016.                            [FR Doc. 2016–22666 Filed 9–20–16; 8:45 am]           Center for Scientific Review; Notice of
                                                    Time: 8:00 a.m. to 5:00 p.m.                          BILLING CODE 4140–01–P                                Closed Meetings
                                                    Agenda: To review and evaluate grant
                                                  applications.                                                                                                   Pursuant to section 10(d) of the
                                                    Place: Residence Inn Alexandria Old                   DEPARTMENT OF HEALTH AND                              Federal Advisory Committee Act, as
                                                  Town, 1456 Duke St, Alexandria, VA 22314.               HUMAN SERVICES                                        amended (5 U.S.C. App.), notice is
                                                    Contact Person: John C. Pugh, Ph.D.,                                                                        hereby given of the following meetings.
                                                  Scientific Review Officer, Center for                   National Institutes of Health                           The meetings will be closed to the
                                                  Scientific Review, National Institutes of                                                                     public in accordance with the
                                                  Health, 6701 Rockledge Drive, Room 1206,                National Heart, Lung, and Blood                       provisions set forth in sections
                                                  MSC 7808, Bethesda, MD 20892, (301) 435–                Institute; Notice of Closed Meeting                   552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
                                                  2398, pughjohn@csr.nih.gov.                                                                                   as amended. The grant applications and
                                                    Name of Committee: Integrative,                         Pursuant to section 10(d) of the
                                                                                                                                                                the discussions could disclose
                                                  Functional and Cognitive Neuroscience                   Federal Advisory Committee Act, as
                                                                                                                                                                confidential trade secrets or commercial
                                                  Integrated Review Group; Mechanisms of                  amended (5 U.S.C. App.), notice is
                                                                                                                                                                property such as patentable material,
                                                  Sensory, Perceptual, and Cognitive Processes            hereby given of a meeting of the Board
                                                  Study Section.                                                                                                and personal information concerning
                                                                                                          of Scientific Counselors, NHLBI. The
                                                    Date: October 17–18, 2016.                                                                                  individuals associated with the grant
                                                                                                          meeting will be closed to the public as
                                                    Time: 8:00 a.m. to 6:00 p.m.                                                                                applications, the disclosure of which
                                                                                                          indicated below in accordance with the
                                                    Agenda: To review and evaluate grant                                                                        would constitute a clearly unwarranted
                                                                                                          provisions set forth in section
                                                  applications.                                                                                                 invasion of personal privacy.
                                                    Place: Washington Plaza Hotel, 10 Thomas              552b(c)(6), title 5 U.S.C., as amended for
                                                                                                          the review, discussion, and evaluation                  Name of Committee: Oncology 1-Basic
                                                  Circle NW., Washington, DC 20005.
                                                                                                          of individual intramural programs and                 Translational Integrated Review Group;
                                                    Contact Person: Kirk Thompson, Ph.D.,
                                                                                                                                                                Tumor Microenvironment Study Section.
                                                  Scientific Review Officer, Center for                   projects conducted by the NATIONAL
                                                                                                                                                                  Date: October 13–14, 2016.
                                                  Scientific Review, National Institutes of               HEART, LUNG, AND BLOOD                                  Time: 8:00 a.m. to 5:00 p.m.
                                                  Health, 6701 Rockledge Drive, Room 5184,                INSTITUTE, including consideration of                   Agenda: To review and evaluate grant
                                                  MSC 7844, Bethesda, MD 20892, 301–435–                  personnel qualifications and                          applications.
                                                  1242, kgt@mail.nih.gov.                                 performance, and the competence of                      Place: Bethesda North Marriott Hotel &
mstockstill on DSK3G9T082PROD with NOTICES




                                                    Name of Committee: Center for Scientific              individual investigators, the disclosure              Conference Center, 5701 Marinelli Road,
                                                  Review Special Emphasis Panel; Vaccine                  of which would constitute a clearly                   Bethesda, MD 20852.
                                                  Related Immune Activation and                                                                                   Contact Person: Angela Y. Ng, MBA, Ph.D.,
                                                                                                          unwarranted invasion of personal
                                                  Immunoregulation.                                                                                             Scientific Review Officer, Center for
                                                    Date: October 18, 2016.                               privacy.                                              Scientific Review, National Institutes of
                                                    Time: 8:00 a.m. to 5:00 p.m.                            Name of Committee: Board of Scientific              Health, 6701 Rockledge Drive, Room 6200,
                                                    Agenda: To review and evaluate grant                  Counselors, NHLBI.                                    MSC 7804, Bethesda, MD 20892, 301–435–
                                                  applications.                                             Date: October 25, 2016.                             1715, ngan@mail.nih.gov.



                                             VerDate Sep<11>2014   18:19 Sep 20, 2016   Jkt 238001   PO 00000   Frm 00053   Fmt 4703   Sfmt 4703   E:\FR\FM\21SEN1.SGM   21SEN1



Document Created: 2016-09-21 01:31:01
Document Modified: 2016-09-21 01:31:01
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesOctober 5, 2016.
FR Citation81 FR 64920 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR